Dirk Reuter

1.5k total citations
27 papers, 1.2k citations indexed

About

Dirk Reuter is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dirk Reuter has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Dirk Reuter's work include Pancreatic and Hepatic Oncology Research (5 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroblastoma Research and Treatments (3 papers). Dirk Reuter is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroblastoma Research and Treatments (3 papers). Dirk Reuter collaborates with scholars based in Germany, United States and Denmark. Dirk Reuter's co-authors include Carsten J. Kirschning, Norbert Lamping, Ralf R. Schumann, Dagmar Pfeil, Claus Belka, Joerg R. Weber, F. Bach, Daniel P. Little, Hubert Köster and Andreas Braun and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Dirk Reuter

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Reuter Germany 19 547 247 242 174 156 27 1.2k
Sophia Derdak Austria 21 800 1.5× 630 2.6× 272 1.1× 243 1.4× 97 0.6× 58 1.9k
Eric P. Dixon United States 13 540 1.0× 435 1.8× 222 0.9× 125 0.7× 481 3.1× 28 1.3k
Sabrina Kraus Germany 19 288 0.5× 250 1.0× 377 1.6× 56 0.3× 46 0.3× 50 990
Francesco Marchesi United Kingdom 14 919 1.7× 213 0.9× 202 0.8× 52 0.3× 141 0.9× 35 1.3k
Masahide Seki Japan 21 1.0k 1.9× 169 0.7× 156 0.6× 33 0.2× 288 1.8× 75 1.5k
Frederick D. Coffman United States 15 513 0.9× 273 1.1× 194 0.8× 62 0.4× 122 0.8× 54 878
P. Sirigu Italy 18 391 0.7× 330 1.3× 281 1.2× 67 0.4× 93 0.6× 64 1.1k
Paula Bertram United States 19 1.3k 2.4× 672 2.7× 97 0.4× 67 0.4× 71 0.5× 30 2.2k
Toma Tebaldi Italy 24 1.6k 2.9× 223 0.9× 229 0.9× 192 1.1× 342 2.2× 64 2.0k
Martin Kerick Germany 24 826 1.5× 276 1.1× 349 1.4× 30 0.2× 431 2.8× 49 1.6k

Countries citing papers authored by Dirk Reuter

Since Specialization
Citations

This map shows the geographic impact of Dirk Reuter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Reuter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Reuter more than expected).

Fields of papers citing papers by Dirk Reuter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Reuter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Reuter. The network helps show where Dirk Reuter may publish in the future.

Co-authorship network of co-authors of Dirk Reuter

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Reuter. A scholar is included among the top collaborators of Dirk Reuter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Reuter. Dirk Reuter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reuter, Dirk, et al.. (2023). Development of new binary expression systems for plant synthetic biology. Plant Cell Reports. 43(1). 22–22. 2 indexed citations
2.
Mazarei, Mitra, et al.. (2022). Specific Bacterial Pathogen Phytosensing Is Enabled by a Synthetic Promoter-Transcription Factor System in Potato. Frontiers in Plant Science. 13. 873480–873480. 10 indexed citations
3.
Occhialini, Alessandro, Lezlee Dice, Li Li, et al.. (2022). Building the Plant SynBio Toolbox through Combinatorial Analysis of DNA Regulatory Elements. ACS Synthetic Biology. 11(8). 2741–2755. 15 indexed citations
4.
Reuter, Dirk, et al.. (2020). The Q-System as a Synthetic Transcriptional Regulator in Plants. Frontiers in Plant Science. 11. 245–245. 20 indexed citations
5.
Fleischhack, Gudrun, Maura Massimino, Monika Warmuth‐Metz, et al.. (2019). Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. Journal of Neuro-Oncology. 143(1). 107–113. 30 indexed citations
6.
Ronellenfitsch, Michael, Pia S. Zeiner, Michel Mittelbronn, et al.. (2018). Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma. Acta Neuropathologica Communications. 6(1). 81–81. 22 indexed citations
7.
8.
Westphal, Manfred, Oliver Heese, Joachim P. Steinbach, et al.. (2015). A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma. European Journal of Cancer. 51(4). 522–532. 156 indexed citations
9.
Mali, Brahim, Markus A. Grohme, Frank Förster, et al.. (2010). Transcriptome survey of the anhydrobiotic tardigrade Milnesium tardigradum in comparison with Hypsibius dujardini and Richtersius coronifer. BMC Genomics. 11(1). 168–168. 44 indexed citations
10.
Strumberg, Dirk, Beate Schultheis, M. E. Scheulen, et al.. (2010). Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. International Journal of Clinical Pharmacology and Therapeutics. 48(7). 473–475. 12 indexed citations
11.
Strumberg, Dirk, Beate Schultheis, M. E. Scheulen, et al.. (2010). Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. Investigational New Drugs. 30(3). 1138–1143. 55 indexed citations
12.
Schill, Ralph O., Brahim Mali, Thomas Dandekar, et al.. (2009). Molecular mechanisms of tolerance in tardigrades: New perspectives for preservation and stabilization of biological material. Biotechnology Advances. 27(4). 348–352. 54 indexed citations
13.
Ehrhart, Friederike, Julia Schulz, Alisa Katsen‐Globa, et al.. (2008). A comparative study of freezing single cells and spheroids: Towards a new model system for optimizing freezing protocols for cryobanking of human tumours. Cryobiology. 58(2). 119–127. 24 indexed citations
14.
Grohme, Markus A., Marcus Frohme, Martina Schnölzer, et al.. (2008). New insights into anhydrobiotic organisms: Perspectives for preservation and stabilization of biological material. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 151(1). S34–S34. 1 indexed citations
15.
Krzywkowski, Karen, Søren Friis, Dirk Reuter, et al.. (2003). Upscaling and Automation of Electrophysiology: Toward High Throughput Screening in Ion Channel Drug Discovery. PubMed. 9(1). 49–58. 44 indexed citations
16.
Fu, Dong‐Jing, Kai Tang, Andreas Braun, et al.. (1998). Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry. Nature Biotechnology. 16(4). 381–384. 104 indexed citations
17.
Kirschning, Carsten J., Janice Au-Young, Norbert Lamping, et al.. (1997). Similar Organization of the Lipopolysaccharide-Binding Protein (LBP) and Phospholipid Transfer Protein (PLTP) Genes Suggests a Common Gene Family of Lipid-Binding Proteins. Genomics. 46(3). 416–425. 60 indexed citations
18.
Braun, Andreas, et al.. (1997). Improved Analysis of Microsatellites Using Mass Spectrometry. Genomics. 46(1). 18–23. 46 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophia Derdak Breakdown of academic impact, for papers by Eric P. Dixon Breakdown of academic impact, for papers by Sabrina Kraus Breakdown of academic impact, for papers by Francesco Marchesi Breakdown of academic impact, for papers by Masahide Seki Breakdown of academic impact, for papers by Frederick D. Coffman Breakdown of academic impact, for papers by P. Sirigu Breakdown of academic impact, for papers by Paula Bertram Breakdown of academic impact, for papers by Toma Tebaldi Breakdown of academic impact, for papers by Martin Kerick
Rankless by CCL
2026